Search research articles
Contact Us
Filters
Showing results (111-120 of 139) with videos related to
Page
of 14
Sort By:
Leukemia & Lymphoma
|
May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy
Karine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
Haematologica
|
October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R
Brian Hess, Alison Moskowitz, James A Davis, et al.
Blood
|
January 24, 2018
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide
Koichi Takahashi, Boyu Hu, Feng Wang, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
British Journal of Haematology
|
January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis
Paolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Frontiers in Immunology
|
February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Gohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Page
of 14
Search research articles
Search
Showing results (111-120 of 139) with videos related to
Sort By:
Page
of 14
Leukemia & Lymphoma
|
May 4, 2021
Prognostic value of disease distribution in secondary central nervous system diffuse large B cell lymphoma treated with radiation therapy
Karine A Al Feghali, Penny Fang, Maria Gule-Monroe, et al.
Haematologica
|
October 30, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R
Brian Hess, Alison Moskowitz, James A Davis, et al.
Blood
|
January 24, 2018
Clinical implications of cancer gene mutations in patients with chronic lymphocytic leukemia treated with lenalidomide
Koichi Takahashi, Boyu Hu, Feng Wang, et al.
JAMA Network Open
|
April 7, 2025
Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy
James P Long, Rishab Prakash, Paul Edelkamp, et al.
Leukemia & Lymphoma
|
January 22, 2021
The impact of cell-of-origin, MYC/Bcl-2 dual expression and <i>MYC</i> rearrangement on disease relapse among early stage diffuse large B-cell lymphoma patients treated with combined modality therapy
Alexander Augustyn, L Jeffrey Medeiros, Ethan B Ludmir, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 20, 2024
Characterization of Lymphopenia and Correlating the Risk of Cytopenias With Dose and Bone Marrow Volume Irradiated in Aggressive B Cell Lymphoma Patients Bridged With Radiation Therapy for Chimeric Antigen Receptor-T Cell Therapy
Gohar S Manzar, Susan Y Wu, Stephanie O Dudzinski, et al.
British Journal of Haematology
|
January 31, 2021
Outcome of relapsed and refractory nodular lymphocyte-predominant Hodgkin lymphoma: a North American analysis
Paolo Strati, Phoebe T M Cheng, Raphael E Steiner, et al.
British Journal of Haematology
|
September 7, 2022
Positron emission tomography derived metrics in relapsed or refractory large B-cell lymphoma with residual disease before autologous stem cell transplant
Hua-Jay J Cherng, Guofan Xu, Lei Feng, et al.
Leukemia
|
September 20, 2022
Impact of conditioning chemotherapy on lymphocyte kinetics and outcomes in LBCL patients treated with CAR T-cell therapy
Paolo Strati, Andrew P Jallouk, Ryan Sun, et al.
Frontiers in Immunology
|
February 17, 2025
Outcomes with bridging radiation therapy prior to chimeric antigen receptor T-cell therapy in patients with aggressive large B-cell lymphomas
Gohar S Manzar, Chelsea C Pinnix, Stephanie O Dudzinski, et al.
Page
of 14